194 related articles for article (PubMed ID: 8590015)
21. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
22. Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.
Reinemer P; Grams F; Huber R; Kleine T; Schnierer S; Piper M; Tschesche H; Bode W
FEBS Lett; 1994 Jan; 338(2):227-33. PubMed ID: 8307185
[TBL] [Abstract][Full Text] [Related]
23. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
[TBL] [Abstract][Full Text] [Related]
24. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.
Lovejoy B; Welch AR; Carr S; Luong C; Broka C; Hendricks RT; Campbell JA; Walker KA; Martin R; Van Wart H; Browner MF
Nat Struct Biol; 1999 Mar; 6(3):217-21. PubMed ID: 10074939
[TBL] [Abstract][Full Text] [Related]
25. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
Grams F; Crimmin M; Hinnes L; Huxley P; Pieper M; Tschesche H; Bode W
Biochemistry; 1995 Oct; 34(43):14012-20. PubMed ID: 7577999
[TBL] [Abstract][Full Text] [Related]
26. The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).
Vallon R; Müller R; Moosmayer D; Gerlach E; Angel P
Eur J Biochem; 1997 Feb; 244(1):81-8. PubMed ID: 9063449
[TBL] [Abstract][Full Text] [Related]
27. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of an active form of human MMP-1.
Iyer S; Visse R; Nagase H; Acharya KR
J Mol Biol; 2006 Sep; 362(1):78-88. PubMed ID: 16890240
[TBL] [Abstract][Full Text] [Related]
29. 1.56 A structure of mature truncated human fibroblast collagenase.
Spurlino JC; Smallwood AM; Carlton DD; Banks TM; Vavra KJ; Johnson JS; Cook ER; Falvo J; Wahl RC; Pulvino TA
Proteins; 1994 Jun; 19(2):98-109. PubMed ID: 8090713
[TBL] [Abstract][Full Text] [Related]
30. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.
Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA
J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
32. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.
Moy FJ; Pisano MR; Chanda PK; Urbano C; Killar LM; Sung ML; Powers R
J Biomol NMR; 1997 Jul; 10(1):9-19. PubMed ID: 9335112
[TBL] [Abstract][Full Text] [Related]
33. Recombinant porcine collagenase: purification and autolysis.
Clark IM; Mitchell RE; Powell LK; Bigg HF; Cawston TE; O'Hare MC
Arch Biochem Biophys; 1995 Jan; 316(1):123-7. PubMed ID: 7840605
[TBL] [Abstract][Full Text] [Related]
34. The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function.
Gohlke U; Gomis-Rüth FX; Crabbe T; Murphy G; Docherty AJ; Bode W
FEBS Lett; 1996 Jan; 378(2):126-30. PubMed ID: 8549817
[TBL] [Abstract][Full Text] [Related]
35. Evidence of reciprocal reorientation of the catalytic and hemopexin-like domains of full-length MMP-12.
Bertini I; Calderone V; Fragai M; Jaiswal R; Luchinat C; Melikian M; Mylonas E; Svergun DI
J Am Chem Soc; 2008 Jun; 130(22):7011-21. PubMed ID: 18465858
[TBL] [Abstract][Full Text] [Related]
36. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.
Smith GN; Mickler EA; Hasty KA; Brandt KD
Arthritis Rheum; 1999 Jun; 42(6):1140-6. PubMed ID: 10366106
[TBL] [Abstract][Full Text] [Related]
37. Structure-based development of a novel collagen inhibitor for MMP-1: re-designing the functions of a matrix protein.
Chen JM; Yeh LA
Front Biosci; 2004 Sep; 9():2788-95. PubMed ID: 15353314
[TBL] [Abstract][Full Text] [Related]
38. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.
Morgunova E; Tuuttila A; Bergmann U; Tryggvason K
Proc Natl Acad Sci U S A; 2002 May; 99(11):7414-9. PubMed ID: 12032297
[TBL] [Abstract][Full Text] [Related]
39. Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity.
Hirose T; Patterson C; Pourmotabbed T; Mainardi CL; Hasty KA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2569-73. PubMed ID: 8464863
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction.
Stricker TP; Dumin JA; Dickeson SK; Chung L; Nagase H; Parks WC; Santoro SA
J Biol Chem; 2001 Aug; 276(31):29375-81. PubMed ID: 11359774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
